Introduction
Chronic inflammation is positively associated with intestinal tumorigenesis (Mager et al, 2016; Eaden et al, 2001; Mizoguchi et al, 2011) . Recent data has particularly implicated the cytokine Interleukin 22 in colorectal cancers (CRC). Consistently, IL-22 producing cells are enriched in human CRC and associated with its development (Jiang et al. 2013; Huang et al. 2015) . IL-22 is produced by type 3 innate lymphoid cells (ILCs), CD4 + and CD8 + T cells and γδ T cells during intestinal inflammation (Mizoguchi, 2012; Pickert et al, 2009; Kryczek et al, 2014; Jiang et al, 2013; Ahlfors et al, 2014) . IL-22 binds to the IL-22 receptor, which is composed of two heterodimeric subunits, IL-22RA1 and IL-10R2 (Xie et al, 2000; Kotenko et al, 2001 ). In the intestine, IL-22 receptor expression is restricted to non-hematopoietic cells, particularly intestinal epithelial cells (IEC) (Nagalakshmi et al, 2004) . IL-22 activates the STAT3 (signal transducer and activator of transcription 3) pathway and regulates intestinal epithelial functions including tissue repair, mucus secretion and antimicrobial activity (Zheng et al, 2008; Pickert et al, 2009; Tsai et al, 2017; Bel et al, 2017; Nagalakshmi et al, 2004; Lindemans et al, 2015; Turner et al, 2013) . Increasing evidence indicates that IL-22 not only facilitates tissue-protection, but also has pro-survival and proliferative effects that can promote colorectal cancer (Lindemans et al, 2015; Huber et al, 2012; Kryczek et al, 2014; Kirchberger et al, 2013) .
Inactivating mutations in the tumour suppressor Adenomatous polyposis coli gene (APC) cause intestinal tumorigenesis and are a major cause of hereditary colorectal cancer (Rowan et al, 2000; Nelson & Näthke, 2013) , a condition known as Familial adenomatous polyposis (FAP).
In FAP patients, adenomatous polyps are present throughout the colon and develop into cancer if left untreated. In addition to FAP, inactivating mutations in the APC gene are present in more than 80% of non-hereditary colorectal cancers (Kinzler & Vogelstein, 1996) . APC is best known as a negative regulator of Wnt signalling, contributing to regulation of cell proliferation and differentiation (Dikovskaya et al, 2007; Nelson & Näthke, 2013; McCartney & Näthke, Chen Y. et al. 4 2008; Stamos & Weis, 2013 (Wang et al, 2014; Putoczki et al, 2013) . Consistent with the idea that IL-22 might also play a role in this process, Il22 -/-Apc Min/+ mice develop smaller and fewer tumours than mice (Huber et al, 2012) . However, it is not clear how IL-22 impacts on APCmutant cells to increase tumorigenesis.
The aim of our study was to understand how IL-22 contributes to intestinal tumorigenesis in (Fig. 1A, S1A ). Overwhelmingly, most of these were involved in immune response and defence against infection and stress (Fig. 1B, C) . These included genes with direct antimicrobial activity (e.g. Reg3g, Lcn2), genes involved in pathogen recognition and immune signaling (e.g. Tmem173 (STING), myd88), genes involved in mucus production and mucin glycosylation (e.g. Fut2, B4galt1), and those involved in the production of reactive nitrogen and oxygen species (e.g. Nos2, Duox1/2) (Fig. 1B) . Other upregulated genes were involved in wound repair (e.g. Areg), and have been recently implicated in colorectal cancer cell proliferation, such as Steap4, a metalloreductase (Xue et al, 2017) and Lrg1 (Zhang et al, 2016) . Notably however, no cell cycle genes were induced by three hours, and many metabolic pathways were downregulated, including the Aryl hydrocarbon receptor pathway, recently implicated in maintaining the intestinal stem cell niche (Metidji et al, 2018) , and cellular lipid metabolism. We also did not find upregulation of genes previously implicated in 'cancer stemness', such as Nanog, Sox2 or DOT1L (Kryczek et al, 2014) . However, we did detect some overlap with genes that have also been found to be upregulated by IL-22 in colonic Chen Y. et al. 6 organoids (Pham et al, 2014) . Notable exceptions were genes involved in retinoic acid metabolism and vasculature development, which were not enriched in SI organoids ( Fig. S1C-D ). In summary, the main role of IL-22 in the small intestine appears to be protection from infection, through synthesis of antimicrobial proteins, increased mucus production, and oxidative stress.
Defective IL-22 mediated gene regulation in APC-mutant IEC
Since IL-22 has been implicated in promoting stemness and proliferation in colorectal cancer cell lines (Kryczek et al, 2014; Kirchberger et al, 2013; Lindemans et al, 2015) , we asked how transformed SI epithelial cells responded to IL-22. We treated transformed Apc Min/Min SI organoids (Langlands et al, 2018) derived from Apc Min/+ mice with IL-22, and performed
RNASeq. In contrast to WT cells, we found only a minute number of genes regulated by in APC-mutant IEC, and these were only detectable when reducing the stringency of the pvalue threshold to p < 0.1 (Fig. S1A) . 10 of the 11 upregulated genes were also induced by IL- . We first measured STAT3 (Aden et al, 2016) , and IFNα activates STAT1 phosphorylation (Giles et al, 2017) . We treated organoids with the designer cytokine, hyper IL-6 (a fusion of the soluble IL-6 receptor (sIL-6R) with IL-6), which bypasses the requirement for the IL-6 receptor α chain to directly activate the gp130 receptor (Fischer et al, 1997) , or with IFNα. We found that hyper IL-6 induced pSTAT3 ( Transcription by STAT3 is affected by a number of factors. In addition to phosphorylation at Tyr705, IL-22 increases the phosphorylation of STAT3 at Ser727, a site required for maximal STAT3 transcriptional activation (Wen et al, 1995) . In contrast to pSTAT3(Y705) induction, which was impaired in Apc Min/Min cells, we did not observe a difference in the level of IL -22 induced pSTAT3 (Ser727) in WT and Apc Min/Min organoids ( Fig. S2C ). Once STAT3 is activated, it recruits coactivators such as Ncoa1 or CBP/p300 to the promoter of a target gene.
In addition, its activity can also be negatively regulated by Type I histone deacetylases (HDAC), PIAS3 (protein inhibitor of activated STAT3), and SOCS3 (Icardi et al, 2012; Yuan et al, 2005; Liu et al, 1997; Giraud et al, 2002; Starr et al, 1997 (Fig. 7A, B) . Moreover, the DNA damage marker γH2AX was increased by IL22 in both WT and Apc Min/+ cells (Fig. 7A,   B ). This suggested that IL-22-induced DNA damage could contribute to loss of heterozygosity and initiate APC mutation-dependent intestinal transformation.
To test this idea, we injected young (4-5 week old) Apc Min/+ mice with low levels (1µg) of IL-22 twice a week for 4 weeks, to mimic underlying inflammation. Indeed, after 5 weeks we found increased numbers of polyps/tumours in the SI of Apc Min/+ mice that had been injected with IL-22, than in animals that had not been injected with IL-22 (Fig. 7C ). These observations support the idea that IL-22 could drive tumorigenesis by promoting LOH in Apc Min/+ cells in mice.
Discussion
The cytokine IL-22 has emerged as an important player in intestinal tumorigenesis. IL-22 can increase cell proliferation (Lindemans et al, 2015) and enhance cancer stemness by increasing expression of core stem cell genes (Kryczek et al, 2014 (Zheng et al, 2008; Behnsen et al, 2014) , through upregulation of mucus production, mucus glycosylation and antimicrobial peptide production. IL-22 producing ILCs can prevent bacterial translocation across the intestinal barrier. Correspondingly, lack of IL-22, or IL-22 receptor contributes to a heightened inflammatory milieu in the intestinal epithelium, and increased sensitivity to bacterial infection due to increased systemic dissemination of bacteria (Vaishnava et al, 2012; Loonen et al, 2014; Pham et al, 2014) . In this context, previous studies showed compromised intestinal barrier integrity and increased inflammation in Apc Min/+ and Apc Floxed/wt ;Cdx2-Cre mice (Li et al, 2012; Grivennikov et al, 2012 (Loonen et al, 2014; Vaishnava et al, 2012 
It is intriguing that APC-mutant cells selectively downregulate IL-22-dependent pSTAT3
signalling, whereas IL-6 induced pSTAT3 is unaffected. One explanation for the lower IL-22R expression could be reduced stability of the protein. The IL-22R is phosphorylated by GSK3, which prevents its proteasomal degradation (Weathington et al, 2014) . In the presence of mutant APC, GSK3 activity is reduced (Valvezan et al, 2014) , which may partially explain the 
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Mutations in APC are found in up to 80% of non-hereditary CRC (Kinzler & Vogelstein, 1996) .
However, we are not suggesting that all transformed epithelial cells cannot respond to IL-22.
When analysing a panel of human cell lines, we found that a subset of them did not respond to IL-22, and some of these had reduced expression of the IL-22 receptor ( (Brand et al, 2006) and data not shown). On the other hand, high levels of IL-22 have been found in many CRC samples, and is associated with CRC development (Jiang et al, 2013; Kirchberger et al, 2013; Huang et al, 2015) . Whether the presence of IL-22 is important at an early stage for the development of tumours, or for maintaining tumour progression is not yet clearly established (Hernandez et al, 2018 
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Materials and methods

Mice and treatment
Intestinal organoid culture and treatment
Small intestine of CL57BL/6J was washed with PBS and was longitudinally opened. Villi were GlutaMax-1 (GIBCO), N-acetylcysteine (10mM, Sigma), N2 (GIBCO) and B27 (GIBCO), 100U/ml penicillin/ 100µg/ml streptomycin (Invitrogen) containing EGF (50ng/ml, GIBCO), Noggin (100ng/ml Peprotech), R-Spondin conditioned-medium, valproic acid (1µM, Sigma) and ROCK Inhibitor Y27632 (Sigma)). After 48-hour incubation, medium was replaced by crypt medium supplemented with EGF, Noggin and R-Spondin. For Apc Min/Min organoid culture, crypt medium containing EGF, Noggin and R-Spondin was used for the first 48 hours.
Apc Min/Min organoids were then cultured in crypt medium alone for at a week before replaced by crypt medium supplied with EGF, Noggin and R-Spondin. Medium was replaced every 2 days.
Organoids were passaged every 4~6 days. Organoids were used for experiments at day 3 after passaging. For IL-22 stimulation experiment, organoids were treated with IL-22 (Peprotech).
Concentration and duration are described in the figure legends. For HDAC inhibition, organoids were incubated with 1mM sodium butyrate (NaBu) (Sigma) for 16 hours before stimulated with IL-22 (10ng/ml) along with media containing 1mM NaBu for 3 hours. (1:500, Invitrogen) and DAPI (1µg/ml, Invitrogen) for 30 minutes. After TBST washes, the cover slides were mounted on glass slides with Prolong Gold Antifade media. Images were analysed in Imaris software (Bitplane) or Fuji software (Schindelin et al, 2012) .
Immunohistochemistry (IHC) staining
Immunofluorescence staining of intestinal organoids
For imaging and immunofluorescence, organoids were grown in Matrigel on 8-well µ-slides Triton X-100) for 1 hour, followed by blocking step with blocking buffer (PBS, 1% BSA, 3% normal goat serum, 0.2% Triton X-100) for 1 hour at room temperature. Organoids were then incubated with primary antibody diluted in working buffer (PBS, 0.1% BSA, 0.3% normal goat serum, 0.2% Triton X-100) overnight at room temperature. Primary antibodies used were as follows: anti-Phospho-Stat3 (Tyr705) (1:100, Cell Signaling, 9131). After washed with working buffer, organoids were incubated with working buffer with Alexa Fluor™ fluorophore conjugated secondary antibody (1:500, Invitrogen) and Hoechst 33342 (5µg/ml, Invitrogen) overnight at room temperature. Organoids were then washed with working buffer and were mounted with ProLong ® Gold antifade mountant (Invitrogen). Immunofluorescence was visualized under Zeiss 710 confocal microscope. Images were analysed by using Imaris software (Bitplane).
Western blotting
Organoids were washed with ice-cold PBS and cell pellets were lysed in lysis buffer (40mM Tris-HCl pH7.5, 120mM NaCl, 0.27M sucrose, 1mM EDTA pH8, 1mM EGTA, 10mM β- 
Quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR)
Total RNA was isolated from organoids by using NucleoSpin RNA isolationKit (MachereyNagel). cDNA was prepared from total RNA by using qScript cDNA synthesis kit (Quanta).
Real-time PCR reaction was performed by using PerfeCTa SYBR green FastMix for iQ (Quanta) in a qPCR machine (Bio-Rad CFX-Connect Real-Time system 
Statistical analysis
Statistical analysis was performed by using Prism 5.0b (GraphPad). were injected twice a week for 4 weeks with 1µg IL-22 or PBS, or were left untreated. Untreated and PBS injected mice were pooled together for the 'control' cohort (there was no difference in the tumour number in these two cohorts). * P<0.05, unpaired t-test.
